Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of cross-linked hemoglobin in treating subarachnoid hemorrhage

Use of cross-linked hemoglobin in treating subarachnoid hemorrhage

US Patent 5854210 · Granted Dec 29, 1998

Estimated economic value: $31,172,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method and matrix for tissue regeneration2024
Multi-dose concentrate esmolol with benzyl alcohol2014
Colored esmolol concentrate2013
Reduced side-effect hemoglobin compositions2007
Reduced side-effect hemoglobin compositions2003
Chemically modified hemoglobin for burn shock resuscitation2003
Therapeutic use of hemoglobin for preserving tissue viability and reducing reste2002
Use of hemoglobin to treat septic shock2000
Therapeutic use of hemoglobin to treat head injury2000
Use of hemoglobin to treat systemic inflammatory response syndrome1999
Therapeutic use of hemoglobin in the treatment of blood vessel blockage1999
Pretraumatic use of hemoglobin1998